The Metrix blog
The reimbursement landscape just changed. Does your FRM team know what to tell their accounts?
Access is a critical driver of both launch success and long-term growth. When reimbursement rules shift, the…
Metrix's top picks
Building field access capability from the ground up: Lessons from a launch-ready team
Field access has quietly become one of the most important levers in a successful launch. Yet in many organizations, it still doesn’t receive the same structured capability investment as sales or medical. That gap shows up in familiar ways: teams can recite the reimbursement landscape but struggle to execute consistently in the field. They “know”…
What keeps NSM strategy alive once the field is back to work?
The ballroom is full. The strategy is clear. The energy…
Why AI makes us more human in training
In life sciences, the most impactful learning experiences don’t just…
Agility in action: How pharma teams can thrive through disruption
Change isn’t coming to pharma, it’s already here. Product lifecycles are shorter. Access challenges…
Stay ahead of the game with regular updates
All results
Why less is more in training: Maximizing ROI under budget constraints
In life sciences, learning and development leaders are navigating a new set of pressures. Teams are expected…
6 Common pitfalls of L&D in pharma and what to do instead
Creating learning programs in the life sciences space is high-stakes. Whether you’re supporting sales teams preparing for…
Emerging digital trends in pharma marketing
In the rapidly evolving pharmaceutical and life sciences sectors, omnichannel marketing has become a pivotal strategy for…
Human + AI in pharma marketing and training: The hybrid approach that’s changing the game
Artificial Intelligence (AI) is no longer a futuristic concept; it’s here, and it’s transforming how life sciences…
Making learning stick: The importance of understanding what our audience cares about
When designing learning, have you ever wondered why some information and behaviors stick, while others don’t make…
- « Previous
- 1
- 2